|
The Stop TB Partnership Challenge Fund for Civil Society (CFCS) is a mechanism to provide financial support to small groups of civil society organizations and for funding advocacy and social mobilization activities at the grass roots level. It is targeted at civil society groups that are seeking to shape policy-making at local and national levels.
95 millions de dollars sont nécessaires en 2007 pour combattre la tuberculose ultrarésistante
LE MONDE | 02.11.06 | 15h19 - Mis à jour le 02.11.06 | 15h19
L'Organisation mondiale de la santé (OMS) et l'Union internationale contre la tuberculose et les maladies respiratoires ont appelé, mardi 31 octobre, les gouvernements et bailleurs de fonds à réunir 95 millions de dollars pour financer la lutte contre la tuberculose "ultrarésistante" en 2007.
Il s'agit de formes de la maladie résistant aux médicaments standards mais aussi aux traitements plus lourds. Des cas ont été signalés en Afrique du Sud, mais aussi aux Etats-Unis et en Lettonie.
450 000 nouveaux cas de tuberculose résistante sont recensés chaque année. Le phénomène est lié à une mauvaise utilisation ou administration des traitements antituberculeux. Parfois, la résistance du bacille peut s'exercer aussi face à des médicaments réservés à l' échec des traitements standards.
Sans pouvoir avancer de chiffre, l'OMS estime que "la tuberculose ultrarésistante est rare" et a décidé de procéder "en urgence à des recherches pour en savoir plus".
La situation est particulièrement préoccupante dans les régions où la co-infection par le virus du sida et la tuberculose est élevée, comme en Afrique du Sud. Le délai pour diagnostiquer une forme ultrarésistante de tuberculose peut aller jusqu'à 16 semaines.
A l'occasion de la conférence mondiale sur la santé respiratoire, qui se tient à Paris du 31 octobre au 4 novembre, l'OMS et l'UICTMR ont détaillé le budget nécessaire pour lutter contre le phénomène en 2007. Il comprend notamment 40 millions de dollars pour l'accès à des médicaments de seconde intention très efficaces et 5 millions de dollars pour des tests de diagnostic rapide
Dans le même temps, Médecins sans frontières (MSF) a rendu public un rapport dans lequel l'ONG indique qu'aucune des molécules actuellement en cours de développement, même si elles sont prometteuses, ne permettra d'améliorer de façon radicale le traitement de la tuberculose dans un futur proche.
"L'OMS doit donc revoir ses priorités en matière de tuberculose et engager des actions concrètes pour accroître les fonds dédiés à la recherche et au développement", estime MSF.
Paul Benkimoun
Article paru dans l'édition du 03.11.06
How to combat extensively drug-resistant TB
2 October 2006
The Global Task Force on extensively drug-resistant TB (XDR-TB) will outline the immediate measures needed to combat the disease at a meeting hosted by WHO in Geneva on October 9-10. XDR-TB is a serious threat to TB control. The Task Force will consider data from all regions where XDR-TB patients have been identified and in some cases successfully treated. International experts attending the Task Force will work to ensure that countries can strengthen TB control and implement extra actions required to urgently respond to XDR-TB.
Frequently asked questions about XDR-TB
XDR-TB Facts at a glance
Report from the Expert Consultation on Drug-Resistant Tuberculosis
Red Cross Red Crescent, leading health agencies form alliance against TB in Europe
10 October 2006
The International Federation of Red Cross and Red Crescent Societies is establishing a new alliance with the World Health Organization (WHO), the European Centre for Disease Prevention and Control (ECDC), Médecins du Monde and 20 other leading European agencies and NGOs to forge a more effective response to the tuberculosis epidemic in the European region. The Stop TB Partnership for Europe is being launched amid growing alarm about high levels of multidrug-resistant tuberculosis (MDR-TB) in the Baltic States, Eastern Europe and Central Asia, and the more recent emergence of extensively drug-resistant tuberculosis (XDR-TB). Senior officials warn that the continued spread of such virulent strains poses a serious threat to TB treatment and control in the region, and challenge the European Union to assume a larger role in tackling the problem.
Read more...
Message from Paul Sommerfeld
TB is a global emergency. The Global Plan to Stop TB 2006-2015 outlines the key areas of work that are necessary to bring TB under control globally. The estimated funding gap for that work is US$31 billion from 2006-2015.
The role of the Global Advocacy for Resource Mobilization sub-group is to create global advocacy initiatives to:
- Help to mobilize the financial resources required to fund fully the Global Plan for 2006-2015 for DOTS expansion, DOTS-Plus for MDR-TB, new tool development, and TB/HIV efforts.
- Encourage a higher profile of TB on national, regional, and international policy agendas.
- Increase political, and mobilize social, support for TB control policies recommended by WHO, including the International Standards of Care, community care activities and the Patients Charter.
- Engage policy-makers, international, regional and national level stakeholders, the media, the private sector, patients, communities and others to secure greater political support for TB control, including through the development and promotion of national partnerships.
- Build the capacity of national TB programmes and partnerships, and other key actors to develop and implement multisectoral, participatory, sustainable ACSM plans, supported by adequate in-country human and financial resources, to improve case detection and treatment outcomes, empower affected communities, and combat stigma and discrimination.
- Build the capacity of civil society and affected communities in donor and endemic countries to advocate for universal access to treatment and mobilize collective action in the fight against TB.
- Promote exchange of information between the Working Groups and the sharing of ACSM-related lessons and experiences to ensure maximum impact, encourage participation and facilitate collaboration.
- Build ACSM indicators and monitoring and evaluation mechanisms into institutional monitoring and evaluation systems.
- The ACSM WG will be responsible for coalescing Stop TB Partnership activities around special events such as the Stop TB Coordinating Board meetings, Heads of State summits including G8 meetings, UNGASS meetings, regional meetings (particularly within Europe, Africa and South East Asia), the annual International Aids Society conference, World TB Day as well as significant launches around TB products.
Roadmap of ACSM events at the Union conference
OSI Media Advisory TB Conference Paris
|
[Apr-16-2007]
African countries should allocate sufficient funds and implement appropriate policies to achieve the U.N. Millennium Development Goals, which include targets to reduce HIV/AIDS, tuberculosis and malaria, advocates said last week, Inter Press Service reports. Representatives from 143 member organizations of the African Civil Society Coalition on HIV/AIDS and Allies at the summit of African Union health ministers in Johannesburg, South Africa, urged African governments to set aside 15% of their national budgets for health care, as well as engage civil society and ministers to mobilize resources to combat TB. Countries also should aim during the next 10 years to bridge the funding gap for TB control of almost $11 billion, the coalition said. "We cannot meet the MDGs at this pace," Regis Mtutu of the Treatment Action Campaign said, adding, "We need to double up our efforts through some extraordinary work, particularly in the areas of HIV/AIDS, TB and malaria." The coalition presented a petition with the recommendations to the A.U. commission for health (Nduru, Inter Press Service, 3/12).
The Lancet (www.thelancet.com)
We read with interest the International Standards for Tuberculosis Care (ISTC) published in the November, 2006 issue of The Lancet Infectious Diseases (1). Focusing primarily on essential activities that all practitioners - public and private- should endorse regarding the management of patients diagnosed with suspected or confirmed tuberculosis, the ISTC brings to the forefront the responsibilities of all providers in delivering quality care to their patients. However, of equal interest is the recent publication of The Patients Charter for Tuberculosis Care (2) which addresses the rights and responsibilities of patients diagnosed with tuberculosis and which was developed in tandem with the ISTC. ...
Action for Global Health has been started simultaneously in Brussels, France, Germany, Italy, Spain and the UK. They are monitoring how the actions and policies of European governments affect health in developing countries. They are inviting other NGOs and civil society organisations to join with them to build a European campaign to ensure that governments, the private sector and European institutions fulfil the promises they have made to reduce the rates of infant and maternal mortality and slowing down the spread of transmissible diseases in the world's poorest countries. To find out more click the link above.
Bulletin of the World Health Organization
Special theme: tuberculosis control; Promising new tools for prevention, detection and cure; How reliable are the data?; The Global Drugs Facility; Barriers to completing treatment; Russian region reports progress; Public health classic: lessons from the past; Interview: Jorge Sampaio, UN special envoy to Stop TB
Global map reveals XDR-TB cases
This month, WHO Stop TB launches a global map illustrating countries where XDR-TB has been confirmed, to coincide with preparations for countries to carry out rapid surveys of drug-resistance, as recommended by the WHO Global Task Force on XDR-TB in October 2006. The surveys will estimate the extent of XDR-TB within at-risk populations, and indicate whether further investigations are required. Laboratory capacity is being strengthened as part of the surveillance strategy, to ensure patients will have improved access to diagnosis and treatment of drug-resistant TB.
UNAIDS aligning with Stop TB
1 December, Geneva
 Today Dr Peter Piot, Executive Director of UNAIDS, called for a collective response to MDR and XDR-TB
Read more here.
Dr Piots' speech to the Stop TB Partnership Coordinating Board
WHO Press Release, Jakarta, Indonesia
29 November 2006 - Killer diseases like tuberculosis (TB) and HIV/AIDS are often forgotten while the whole world’s attention is now focusing on new emerging and epidemic/ pandemic potential diseases.
Read More
The number of ACSM Working Group members is: 281.
|
How is the sub-group
Media and Events
